Trump SLASHES Vaccines — 28 States Revolt in Chaos

President Trump’s directive to overhaul childhood vaccine recommendations has triggered a nationwide fracture in public health policy, with 28 states outright rejecting the CDC’s new streamlined schedule in favor of maintaining broader immunization protocols.

Story Snapshot

Trump administration slashes routine childhood vaccines from 17 to 11, shifting six to “high-risk only” status despite ongoing disease outbreaks
28 states plus DC reject federal changes, creating two competing vaccine schedules and unprecedented confusion for parents nationwide
American Academy of Pediatrics and 200+ medical groups demand Congressional investigation, calling the rapid process “reckless and dangerous”
New policy bypassed traditional public input processes, raising concerns about transparency and erosion of established scientific safeguards

Trump Administration Breaks With Decades of Vaccine Policy

President Trump issued a Presidential Memorandum, directing the Department of Health and Human Services and CDC to review childhood immunization schedules based on international models.

Acting CDC Director Jim O’Neill signed the decision memorandum, formally accepting a revised schedule that retains universal recommendations for only 11 vaccines, including measles, mumps, rubella, polio, and HPV.

Six previously routine vaccines—RSV, hepatitis A and B, influenza, rotavirus, and meningococcal—now require “shared clinical decision-making” only for high-risk cases.

This represents the most dramatic shift in federal vaccine policy in generations, implemented without the traditional Advisory Committee on Immunization Practices public process.

'US committee is reconsidering all vaccine recommendations'

"Move is dramatic departure for advisory group [Advisory Committee on Immunization Practices (ACIP)] under Kirk Milhoan, who says he doesn’t like the term ‘established science’"
https://t.co/C6gjckmI6A

— Andy_Weeble_Weaver😷⚫🦋andy-weaver.bsky.social🗿 (@AndrewW66619812) February 1, 2026

States Reject Federal Guidance Amid Medical Community Pushback

28 states, including California, New York, and Massachusetts, have rejected the CDC’s revised schedule for at least some vaccines, with 25 states relying entirely on nonfederal guidance.

This surge in 22 states in September 2025 reflects growing state resistance to what many health officials view as federal overreach, undermining proven disease prevention measures. The American Academy of Pediatrics published its 2026 schedule as an alternative, maintaining all 17 vaccines as routine recommendations.

AAP trustee Dr. Sandra Adamson Fryhofer condemned the changes as lacking “rigor and transparency,” while Massachusetts health officials publicly stated the new guidance “abandons science amid outbreaks” of measles, pertussis, and influenza.

HHS Leadership Champions Transparency Over Traditional Consensus

HHS Secretary Robert F. Kennedy Jr. championed the review, emphasizing alignment with countries like Denmark, Japan, and Germany that use fewer routine vaccines and target high-risk populations. NIH Director Dr. Jay Bhattacharya stated the changes “commit to gold standard science” through planned placebo-controlled trials to address evidence gaps.

The administration argues the overhaul restores parental informed consent and rebuilds public trust eroded during 2020-2024, when vaccination rates declined sharply.

Kennedy framed the policy as protecting children while respecting families’ rights, directly challenging decades of ACIP consensus-building that conservatives have long criticized as insulated from accountability and real-world concerns about vaccine proliferation.

Parents Face Confusion as National Immunization Unity Collapses

The fractured landscape leaves parents navigating two competing schedules with no clear federal-state consensus, creating practical chaos in pediatric offices and pharmacies nationwide.

Clinicians in non-adopting states face potential conflicts between federal guidance and state mandates, raising liability concerns and complicating insurance coverage decisions.

In late January 2026, the AAP and more than 200 medical organizations urged Congress to investigate the rushed process, arguing that public health decisions require transparent scientific review, not executive fiat.

Critics warn the shift to high-risk targeting for six vaccines could increase disease vulnerability among children in rural and low-trust communities already experiencing outbreaks, potentially fracturing national immunity built over decades of broad immunization.

The long-term consequences remain uncertain, but the immediate effect is unmistakable: federal authority over childhood vaccines has eroded, replaced by state-by-state decisions that reflect deep political and philosophical divides over parental rights, government mandates, and scientific consensus.

For conservatives frustrated by decades of expanding vaccine schedules implemented without robust public debate, the Trump directive represents long-overdue accountability.

Yet the chaotic rollout and state-level rejections underscore the complexity of dismantling entrenched public health systems, even when the effort is motivated by legitimate concerns about transparency and parental autonomy rather than unchecked bureaucratic expansion.